169 related articles for article (PubMed ID: 6971812)
41. [Complement subcomponent C1q in rheumatic diseases].
Yonemasu K; Sasaki T
Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
[No Abstract] [Full Text] [Related]
42. The first component of human complement (C1): activation and control.
Ziccardi RJ
Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
[TBL] [Abstract][Full Text] [Related]
43. Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen.
Heinz HP; Brackertz D; Loos M
FEBS Lett; 1988 Feb; 228(2):332-6. PubMed ID: 2830144
[TBL] [Abstract][Full Text] [Related]
44. Antibody-independent interactions between Escherichia coli J5 and human complement components.
Betz SJ; Isliker H
J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
[TBL] [Abstract][Full Text] [Related]
45. Characterization of C1q found in a patient with hypocomplementemic vasculitis-urticaria syndrome.
Sasaki T; Yonemasu K; Matsumoto M; Nagaki K
Microbiol Immunol; 1989; 33(5):413-22. PubMed ID: 2502705
[TBL] [Abstract][Full Text] [Related]
46. Interaction of C1q with beta 2-microglobulin.
Björck L; Johnson U; Sjöholm AG
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
Niven IP; Whaley K
Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
[TBL] [Abstract][Full Text] [Related]
48. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
49. Antibody-independent killing of gram-negative bacteria via the classical pathway.
Clas F; Loos M
Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
[TBL] [Abstract][Full Text] [Related]
50. Guinea pig macrophages synthesize a low molecular weight form of C1q with affinity for the C1r2C1s2-complex but which does not bind to Fc in immunoglobulin aggregates.
Martin H; Loos M
Mol Immunol; 1988 Dec; 25(12):1231-7. PubMed ID: 2853293
[TBL] [Abstract][Full Text] [Related]
51. C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain.
Wright JF; Shulman MJ; Isenman DE; Painter RH
J Biol Chem; 1988 Aug; 263(23):11221-6. PubMed ID: 3136155
[TBL] [Abstract][Full Text] [Related]
52. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
53. Contributions of C1q, bacterial lipopolysaccharide, and porins during attachment and ingestion phases of phagocytosis by murine macrophages.
Euteneuer B; Störkel S; Loos M
Infect Immun; 1986 Mar; 51(3):807-15. PubMed ID: 3005172
[TBL] [Abstract][Full Text] [Related]
54. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
55. Antibody-independent activation of C1, the first component of complement.
Loos M
Ann Immunol (Paris); 1982; 133C(2):165-79. PubMed ID: 6287904
[No Abstract] [Full Text] [Related]
56. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
Tacnet-Delorme P; Chevallier S; Arlaud GJ
J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.
Reid KB; Sim RB; Faiers AP
Biochem J; 1977 Feb; 161(2):239-45. PubMed ID: 322655
[TBL] [Abstract][Full Text] [Related]
58. Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.
Perkins SJ
Biochem J; 1985 May; 228(1):13-26. PubMed ID: 2988513
[TBL] [Abstract][Full Text] [Related]
59. Subunit interactions in the first component of complement, C1.
Lakatos S
Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
[TBL] [Abstract][Full Text] [Related]
60. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
Hsiung L; Dodds AW; Mason DW; Reid KB
FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
